重大公告
OBI Pharma Inc. to attend the 2018 Asia Pacific Healthcare Forum, hosted by Goldman Sachs
1.Date of the event: Nov 27 ~ Nov 28, 2018 2.Time: 09:00:00 CST 3.Location: Jw Marriott Hotel Hong Kong Level 3 Ballroom 4.Summary: OBI Pharma …
Clarification on the news article by Up Media and other media groups
Date of occurrence of the event: Nov 23, 2018 Company name: OBI Pharma Inc./ AP Biosciences Inc. Relationship to the Company (please enter “head office” …
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
Date of occurrence of the event: Nov 21, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head …
Department of Health (DOH) clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study in Hong Kong
Date of occurrence of the event: Nov 15, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head …
Investigational Device Exemption (IDE) for the development of OBI-888 was approved by the US Food and Drug Administration (FDA) for its use in OBI-888 Phase I cohort expansion phase
Date of occurrence of the event: Nov 12, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head …